Application 212278
- Type
- ANDA
- Sponsor
- HETERO LABS LTD III
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 150MG BASE | No | No |
| 002 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 200MG BASE | No | No |
| 003 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | CAPSULE;ORAL | EQ 300MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 31722-653 | Atazanavir | Atazanavir | Camber Pharmaceuticals, Inc. | ANDA | Current |
| 31722-654 | Atazanavir | Atazanavir | Camber Pharmaceuticals, Inc. | ANDA | Current |
| 31722-655 | Atazanavir | Atazanavir | Camber Pharmaceuticals, Inc. | ANDA | Current |